Letter: HRS-AKI - a frequent misdiagnosis in the real-world setting?
- PMID: 33119170
- DOI: 10.1111/apt.15964
Letter: HRS-AKI - a frequent misdiagnosis in the real-world setting?
Comment in
-
Letter: HRS-AKI-a frequent misdiagnosis in the real world setting? Authors' reply.Aliment Pharmacol Ther. 2020 Sep;52(6):1092. doi: 10.1111/apt.16001. Aliment Pharmacol Ther. 2020. PMID: 33119161 No abstract available.
Comment on
-
Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome.Aliment Pharmacol Ther. 2020 Jul;52(2):351-358. doi: 10.1111/apt.15836. Epub 2020 Jun 4. Aliment Pharmacol Ther. 2020. PMID: 32495956 Free PMC article.
References
REFERENCES
-
- Moore K, Jamil K, Verleger K, et al. Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome. Aliment Pharmacol Ther. 2020;52:351-358.
-
- Boyer TD, Sanyal AJ, Garcia-Tsao G, et al. Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J Hepatol. 2011;55:315-321.
-
- Singh V, Ghosh S, Singh B, et al. Noradrenaline vs terlipressin in the treatment of hepatorenal syndrome: a randomized study. J Hepatol. 2012;56:1293-1298.
-
- Sharma P, Kumar A, Sharma BC, et al. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Am J Gastroenterol. 2008;103:1689-1697.
-
- Gupta K, Rani P, Rohatgi A, et al. Noradrenaline for reverting hepatorenal syndrome: a prospective, observational, single-center study. Clin Exp Gastroenterol. 2018;11:317-324.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources